Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension

References

• AdamsonI1999Irreversible corneal decompensation in patients treated with topical dorzolamideAm J Ophthalmol128774510612524
   PubMed Web of Science ®Google Scholar
• AGIS Investigators2000The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deteriorationAm J Ophthalmol1304294011024415
   PubMed Web of Science ®Google Scholar
• BarnesGEWilhelmFSchochC2000Increased optic nerve head blood flow after 1 week of twice daily topical brinzolamide treatment in Dutch-belted rabbitsSurv Ophthalmol44S131S4010665515
   PubMed Web of Science ®Google Scholar
• BonomiLMarchiniGMaraffaM2000Vascular risk factors for primary open angle glaucomaOphthalmology10712879310889099
   PubMed Web of Science ®Google Scholar
• BudenzDLAndersonDRFeuerWJ2006Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment StudyOphthalmology11321374316996592
   PubMed Web of Science ®Google Scholar
• CarlssonAMChauhanBCLeeAA2000The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertensionAm J Ophthalmol12929730110704543
   PubMed Web of Science ®Google Scholar
• Collaborative Normal-Tension Glaucoma Study Group1998The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAm J Ophthalmol1264985059780094
   PubMed Web of Science ®Google Scholar
• CostaVPHarrisAStefanssonE2003The effects of antiglaucomatous and systemic medications on ocular blood flowProgr Retin Eye Res22769805
   PubMed Web of Science ®Google Scholar
• CvetkvicRSPerryCM2003Brizolamide. A review of its use in the management of Primary open-angle glaucoma and ocular hypertensionDrug Aging2091947
   PubMed Web of Science ®Google Scholar
• DeSantisL2000Preclinical overview of brinzolamideSurv Ophthalmol44Suppl 2S119S12910665514
   PubMed Web of Science ®Google Scholar
• European Glaucoma SocietyTerminology and Guidelines 2003SavonaDogma
   Google Scholar
• FaraciFMHeistadDDMayhamWG1987Role of larger arteries in regulation of blood flow to the brain stem in catsJ Physiol3871125
   Web of Science ®Google Scholar
• FeldmanRMTannaAPGrossRL2007Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%Ophthalmology11412485417509688
   PubMed Web of Science ®Google Scholar
• FranksW2006Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with open-angle glaucoma or ocular hypertensionCurr Med Res Opin221643916968567
   PubMed Web of Science ®Google Scholar
• GalassiFNuzzaciGSodiA1992Color Doppler imaging in evaluation of optic nerve blood supply in normal and glaucomatous subjectsInt Ophthalmol1627361428556
   PubMed Web of Science ®Google Scholar
• GherghelDOrgulSGugletaK2000Relation between ocular perfusion and retrobulbar blood flow in patients with glaucoma with progressive damageAm J Ophthalmol13059760511078838
   PubMed Web of Science ®Google Scholar
• GrieshaberMCMozaffariehMFlammerJ2007What is the link between vascular dysregulation and glaucoma?Surv Ophthalmol52Suppl 2S1445417998040
   PubMed Web of Science ®Google Scholar
• HarrisAArendOArendS1996Effects of topical dorzolamide on retinal and retrobulbar hemodynamicsActa Opthalmol Scand7456972
   PubMedGoogle Scholar
• HarrisAArendOKagemannL1999Dorzolamide, visual function and ocular hemodynamics in normal tension glaucomaJ Ocular Pharm Ther1518997
   PubMed Web of Science ®Google Scholar
• HaugeANicolaysenGThoresenM1983Acute effects of acetazolamide on cerebral blood flow in manActa Physiol Scand11723396869033
   PubMedGoogle Scholar
• HeijlALeskeMCBengtssonB2002Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol12012687912365904
   PubMed Web of Science ®Google Scholar
• HolloGChiselitaDPetkovaN2006The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open-angle glaucomaEur J Ophthalmol168162317191187
   PubMed Web of Science ®Google Scholar
• IesterMAltieriMMichelsonG2003Retinal peripapillary blood flow before and after topical brinzolamideOphthalmologica2183906
   Web of Science ®Google Scholar
• IesterM2008BrinzolamideExpert Opin Pharmacother96536218312166
   PubMed Web of Science ®Google Scholar
• IngramCJBrubakerRF1999Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyesAm J Ophthalmol128292610511022
   PubMed Web of Science ®Google Scholar
• KassMAHeuerDKHigginbothamEJ2002The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open–angle glaucomaArch Ophthalmol1207011312049574
   PubMed Web of Science ®Google Scholar
• KaupMPlangeNNiegelM2004Effects of brinzolamide on ocular haemodynamics in healthy volunteersBr J Ophthalmol882576214736787
   PubMed Web of Science ®Google Scholar
• KaurIPSmithaRDeepikaA2002Acetazolamide: future perspective in topical glaucoma therapeuticsInt J Pharm24811412429455
   PubMed Web of Science ®Google Scholar
• KonowalAMorrisonJCBrownSVL1999Irreversible corneal decompansation in patients treated with topical dorzolamideAm J ophthalmol127403610218692
   PubMed Web of Science ®Google Scholar
• KothyPHolloG2001Does glaucoma medication influence the diameter of the retinal arteriole in the human eyes? (A pilot study using the retinal vessel analyser)Aca Phisiol Hungarica8828192
   PubMedGoogle Scholar
• LeskeMCConnellAMWuSY1995Risk factors for open-angle glaucoma. The Barbados Eye StudyArch Ophthalmol113918247605285
   PubMed Web of Science ®Google Scholar
• LeskeMCHeijlAHusseinM2003Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trialArch Ophthalmol121485612523884
   PubMed Web of Science ®Google Scholar
• LeskeMCHeijlAHymanL2007EMGT Group. Predictors of long-term progression in the early manifest glaucoma trialOphthalmology11419657217628686
   PubMed Web of Science ®Google Scholar
• MarchWFOchsnerKI2000The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study GroupAm J Ophthalmol1291364310682964
   PubMed Web of Science ®Google Scholar
• MarenTH1967Carbonic anhydrase: chemistry, physiology, and inhibitionPhysiol Rev475957814964060
   PubMed Web of Science ®Google Scholar
• Martinez-de-la-CasaJMCastilloAGarcia-FeijooJ2004Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safetyCurr Med Res Opin201333915383180
   PubMed Web of Science ®Google Scholar
• MenonGJVernonSA2006Topical brinzolamide and metabolic acidosisBr J Ophthalmol902478
   PubMed Web of Science ®Google Scholar
• MichaudJEFrirenB2001Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertensionAm J Ophthalmol1322354311476685
   PubMed Web of Science ®Google Scholar
• NakamotoKYasudaN2007Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucomaJ Glaucoma16352717570997
   PubMed Web of Science ®Google Scholar
• NicolelaMTDranceSM1996Various glaucomatous optic nerve appearances: clinical correlationsOphthalmology10364098618765
   PubMed Web of Science ®Google Scholar
• PedersonJEAndersonDR1980The mode of progressive disc cupping in ocular hypertension and glaucomaArch Ophthalmol9849057362506
   PubMed Web of Science ®Google Scholar
• QuigleyHAWestSKRodriguezJ2001The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VERArch Ophthalmol11918192611735794
   PubMed Web of Science ®Google Scholar
• ReisRQueirozCFSantosLC2006A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertensionClin Ther28552916750466
   PubMed Web of Science ®Google Scholar
• RingelsteinEBVan EyckSMertensI1992Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: comparison of CO2 to acetazolamideJ Cerebral Blood Flow121628
   PubMed Web of Science ®Google Scholar
• SallK2000The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study GroupSurv Ophthalmol44Suppl 2S155S16210665518
   PubMed Web of Science ®Google Scholar
• SampaolesiJTosiJDarchukV2001Antiglaucomatous drugs effects on optic nerve head flow: design, baseline and preliminary reportInt Ophthalmol233596711944863
   PubMedGoogle Scholar
• SchulzerMDranceSM1987Intraocular pressure, systemic blood pressure, and age: a correlational studyBr J Ophthalmol7124593580336
   PubMed Web of Science ®Google Scholar
• SeveringhausJWCotevS1968Carbonic acidosis and cerebral vasodilatation after diamoxScand J Clin Lab Invest221E4236696
   PubMed Web of Science ®Google Scholar
• ShinD2000Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapySurv Ophthalmol44Suppl 2S163S16810665519
   PubMed Web of Science ®Google Scholar
• ShojiNOgataHSuyamaH2005Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label studyCurr Med Res Opin21503815899098
   PubMed Web of Science ®Google Scholar
• ShojiN2007Brinzolamide: efficacy, safety and its role in the management of glaucomaExpert Rev Ophthalmol2695704
   Google Scholar
• SieskyBLinTKagemannL2006Comparison of three months treatment with dorzolamide and brinzolamide on perfusion pressures in primary open angle glaucoma patientsInternational Symposium on Ocular Pharmacology and TherapeuticsApril, 2006Berlin
   Google Scholar
• SilverLH1998Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study GroupAm J Ophthalmol12640089744373
   PubMed Web of Science ®Google Scholar
• SilverLH2000Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt). Brinzolamide Dose-Response Study GroupSurv Ophthalmol44Suppl 2S147S5310665517
   PubMed Web of Science ®Google Scholar
• SponselWEShipmanDLDranceSChauhanB1997The role of blood gases in ocular perfusionOcular blood flowAmsterdamKugler3
   Google Scholar
• TielschJMKatzJSommerA1995Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessmentArch Ophthalmol113216217864755
   PubMed Web of Science ®Google Scholar
• Van der ValkRWebersCABSchoutenJSAG2005Intraocular pressure-lowering effects of all commonly used glaucoma drugs. A meta-analysis of randomized clinical trialsOphthalmology11211778515921747
   PubMed Web of Science ®Google Scholar
• VolstrupSHenrikenLPaulsonDB1984Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate oxigenJ Clin Invest74163496501565
   PubMed Web of Science ®Google Scholar
• WangTHHuangJYHungPT2004Ocular hypotensive effect and safety of brinzolamide ophthalmic solution in open angle glaucoma patientsJ Formos Med Assoc1033697315216404
   PubMed Web of Science ®Google Scholar
• ZeyenTGCaprioliJ1993Progression of disc and field damage in early glaucomaArch Ophthalmol1116258424726
   PubMed Web of Science ®Google Scholar
• ZhaoJCChenT2005Brinzolamide induced reversible corneal decompensationBr J Ophthalmol893899015722328
   PubMed Web of Science ®Google Scholar